Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.43 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL17865366 | 0.96 | CA4 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL28177417 | 0.96 | CA4 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL27996776 | 0.96 | CA4 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL3830823 | 0.96 | CA4 (0.50) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL28087376 | 0.96 | CA4 (0.50) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL28177416 | 0.96 | CA4 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL9722913 | 0.96 | CA4 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL6136850 | 0.92 | MEN1 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL5015852 | 0.92 | MEN1 (0.50) | CA4FAHD1MEN1KMT2AALDH1A1 | |
| Sulfuric Acid SCHEMBL3904958 | 0.92 | MEN1 (0.40) | CA4FAHD1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2312944-B1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS INC (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9061060-B2 | Deuterated benzylbenzene derivatives and methods of use | THERACOS INC. (US) | 2015-06-23 | — | — | US | disclosed |
| EP-2312944-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | Theracos, Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| US-20100063141-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS, INC. (US) | 2010-03-11 | — | — | US | disclosed |
| WO-2010009243-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS, INC. (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063141-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | SLC5A1, SLC5A2, SLC2A4 | CA4 426/4885FAHD1 3035/4885MEN1 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.